AGP Wire

AGP

Nebula Personalization Tech Solutions Pvt. Ltd. has launched a Generative Engine Optimization framework aimed at helping manufacturers, exporters and pharma companies win citations inside ChatGPT, Perplexity and AI Overviews.

AGP

World Health Expo will expand its 2027 Dubai edition with new Pharma, Biotech, Longevity and Wellness sectors as healthcare investment pours into the GCC. The show is expected to draw more than 90,000 attendees and 4,200 exhibitors across two…

AGP

The Business Research Company says the smart exoskeleton market will grow from $4.77 billion in 2026 to $8.01 billion by 2030 as demand rises in defense, rehabilitation and industrial use. North America led the market in 2025, while Asia-Pacific…

AGP

The Business Research Company says the plasmonic laser ablation device market will grow from $1.65 billion in 2026 to $2.43 billion by 2030, driven by demand for minimally invasive procedures, higher healthcare spending and more clinical trials….

AGP

Foshan Fumei Health Industry Co., Ltd. says its sauna blanket manufacturing is built around tighter thermal control, broader certifications, and integrated production at its Foshan facility.

AGP

Foshan Fumei Health Industry Co., Ltd. says its infrared sauna blankets have earned CE and UL-aligned certification support as demand for home wellness devices grows in Europe and North America.

AGP

India’s contract research organization market is forecast to grow from $6.74 billion in 2025 to $12.0 billion by 2035, driven by pharma R&D, rising clinical trial activity and supportive policy shifts.

AGP

The global molecular sieves market is projected to grow from $4.70 billion in 2026 to $7.23 billion by 2035, driven by emissions rules, refinery buildouts and new uses in hydrogen purification and biogas upgrading.

AGP

The medical rubber stoppers market is projected to grow from $2.09 billion in 2025 to $2.27 billion in 2026, with the market expected to reach $3.16 billion by 2030. Demand for sterile pharmaceutical packaging, injectable drugs and biologics is…

AGP

LifeActive Bio has appointed internationally recognized cardiologist and healthcare innovator Dr. John L. Jefferies to its board of directors as it pushes its XnanodeX delivery platform across multiple markets.

AGP

Dongguan Bayi Automation Equipment Co., Ltd. was listed among the top 10 jewelry plasma polishing equipment suppliers in China for 2026, alongside nine other registered companies.

AGP

The global laboratory robotics market was valued at $2.93 billion in 2025 and is projected to hit $4.64 billion by 2030, driven by automation demand in research and diagnostic labs.

AGP

The Business Research Company says the in-line UV-Vis spectroscopy market will grow from $1.25 billion in 2025 to $1.81 billion by 2030, driven by demand for real-time chemical analysis, process monitoring and automated manufacturing.

AGP

Persistence Market Research projects the global pharmaceutical packaging market will grow from $131.2 billion in 2025 to $198.7 billion by 2032, driven by higher drug production, stronger safety requirements, and demand for smarter, more…

AGP

GenBio Inc. says the looming patent cliff is pushing major drugmakers to seek outside biotechnology innovation as more than $230 billion in biopharma revenue and potentially more than $300 billion in prescription-drug sales face loss of…

AGP

InstantGMP has published exact annual pricing for each software module and bundle on its website, giving manufacturers a way to compare costs before booking a sales call.

AGP

Televero Behavioral Health earned its second straight Inc. 5000 honor, landing at No. 364 after posting 961% three-year revenue growth and expanding to 43 states.

AGP

A new Israel Innovation Authority survey finds Israel’s high-tech workforce held steady in early 2026 even as software companies cut jobs and hardware firms kept hiring.

AGP

Lumea ranked No. 1,641 on the 2026 Inc. 5000, up from No. 2,468 a year earlier, as the Lehi, Utah, digital pathology company posted continued revenue growth.

AGP

The market for desmoplastic small round cell tumor treatment is projected to rise from $4.01 billion in 2025 to $5.92 billion by 2030, according to The Business Research Company.